Rallis India Ltd

The transcript does not mention any current or planned fundraising through debt or equity. Key points related to financial strategy include: - Focus on improving capital efficiency across fixed and working capital. - Maintaining healthy cash and liquid balance of ₹541 crore as of March 31, 2026. - No indication of plans for raising funds through debt or equity in near term. - Inventory build-up is strategic and calibrated; no excess holding to avoid financial risk. - Emphasis on disciplined capital management without explicit mention of external fundraising. Therefore, based on the available information, Rallis India Limited currently has no disclosed plans for new debt or equity fundraising.

- The company is investing in the aquafeed business, currently at an experimental stage with sales over INR 50 crores. - They plan to evaluate this business for one more year before deciding on further investment. - The aquafeed venture is seen as exciting and akin to the soil and plant health business 5-7 years ago, with potential for 1-2 more cycles before reaching scale. - In seed R&D, rather than investing heavily in gene editing technology development in-house, Rallis prefers licensing technologies from global multinationals, leveraging their larger R&D. - The company is launching a technology-led rice seed business (Paryan technology) bundling seed with herbicide, relying on licensed herbicide-tolerant gene technology. - Overall, Rallis will focus strategic investment selectively, leveraging partnerships and licensing for technology access instead of long-term heavy R&D investment.

- Seeds business expected to deliver high double-digit growth next year, around mid to high teens, combining volume and price growth, driven by key crops: cotton, maize, millet, mustard, and rice. - Crop Care segment sees focused growth in herbicides, soil & plant health, and seed sales rather than insecticides or diseases, with volume growth expected to be marginal positive in crop protection (low single digit). - Aquafeed business is at an experimental stage with potential akin to soil and plant health 5-7 years ago; expected to need 1-2 more years to mature before scaling investments. - Industry growth projected around 3-4% corresponding to GDP growth, with Rallis aiming for consistent and profitable growth through portfolio rationalization and market focus. - B2C crop protection business growth excluding soil and plant health was flattish to marginally positive this quarter. - Export volumes showed a decline, but CSM and B2B businesses showed volume and price growth, contributing positively.

- Seeds segment expected to deliver high double-digit growth (mid-teens) in next year driven by key crops: cotton, maize, millet, mustard, and rice. Growth is a combination of volume and price increases. - Crop Protection B2C business growth excluding Soil & Plant Health (SPH) will be marginally positive to low single digit; SPH segment grew robustly at 27%. - Overall sector growth expected in line with GDP growth at 3-4%. - Margins in Crop Protection expected to be stable to soft due to price increases needed to offset 15-20% higher input costs; margin improvement possible from operating leverage but uncertain due to competition and commodity prices. - Emphasis on expanding higher-margin, sustainable, and farmer-centric offerings including biologicals and digital initiatives to improve profitability. - Capital efficiency improvements and portfolio rationalization efforts ongoing to enhance operational efficiency and profitability. - Overall, company targets consistent and profitable growth.

The provided transcript from Rallis India Limited’s earnings call does not explicitly mention details about the current or expected order book or pending orders. However, relevant insights related to inventory and order management include: - Inventory levels remain slightly elevated compared to the same quarter last year, primarily due to preparation for uncertainties like war impacting raw material costs. - The company is building inventory cautiously, focusing on what can be sold rather than overstocking, particularly protecting the kharif season inventory. - There is ongoing active monitoring and daily business planning to manage inventory and supply chain risks. - No explicit guidance or figures on order book or pending orders were disclosed during this call. If further details on order book are needed, company filings or investor relations releases would be the likely sources.